Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Asim Sarfaraz"'
Autor:
Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Manjhi, Deependra Kumar Rai, Shyama, Anjani Kumar, Asim Sarfaraz
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 24, Iss 3 (2021)
Background: There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in m
Externí odkaz:
https://doaj.org/article/40f9b2bf0f1b41ca876301f15ab1ab8d
Autor:
Satish P Dipankar, Tribhuwan Kumar, Afreen Begum H Itagi, Bijaya N Naik, Yogesh Kumar, Mona Sharma, Asim Sarfaraz, Amita Kumari
Publikováno v:
Cureus.
Background It is well known that some viral infections may affect male fertility. Coronavirus disease (COVID-19) can lead to multiorgan damage through the angiotensin-converting enzyme-2 receptor, abundant in testicular tissue. However, little inform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e583076ddf93b3b64c07558c9e2113c
https://doi.org/10.7759/cureus.31776
https://doi.org/10.7759/cureus.31776
Autor:
Neeraj Agarwal, Asim Sarfaraz, Ravikirti, Bijit Biswas, Chandrima Pattadar, Ranjini Roy, Rishav Raj, Shyama, Pramod Kumar Manjhi, Anjani Kumar, Deependra Kumar Rai
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 24, Iss 3 (2021)
Background: There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c8971389a746b950baee0ef39fe205
https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32105
https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32105
Autor:
Asim Sarfaraz, Bijit Biswas, Shyama, Rishav Raj, Neeraj Agarwal, Chandrima Pattadar, Pramod Kumar Majhi, Ranjini Roy, Anjani Kumar, Ravikirti, Deependra Kumar Rai
ObjectiveIvermectin has been suggested as a treatment for COVID-19.This randomised control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and moderate COVID-19.DesignParallel, double blind, randomised, placebo control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45cadba931ed248b7f007b28458f43f8
https://doi.org/10.1101/2021.01.05.21249310
https://doi.org/10.1101/2021.01.05.21249310
